M1 Kliniken AG

Research M1 Kliniken AG (M12) on Bullrun: market cap EUR 345.90M, P/E 15.5, dividend yield 6.3%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 345.90M; P/E is 15.5; dividend yield is 6.3%.

Peer valuation comparison

Latest P/E is 15.48x versus a Healthcare sector median of 24.46x (36.7% below).

Latest dividend yield is 6.3% versus a Healthcare sector median of 2.11% (198.6% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025EUR 364.30MEUR 22.13MEUR 37.84M22.7%1.19EUR 37.76MEUR 7.15MEUR 119.93M
FY2024EUR 339.18MEUR 16.02MEUR 29.55M18.8%0.85EUR 21.43MEUR 10.42MEUR 106.10M
FY2023EUR 316.32MEUR 10.27MEUR 6.80M15.9%0.54EUR 22.38MEUR 10.79MEUR 113.25M
FY2022EUR 285.29MEUR 4.32MEUR 19.00M18.5%0.24EUR 35.15MEUR 13.70MEUR 95.52M
FY2021EUR 314.61MEUR 8.91MEUR 14.35M17.6%0.45EUR 37.87MEUR 11.78MEUR 95.03M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-28EUR 345.90M15.56.5%1.2

Dividend history

Latest trailing dividend snapshot: annual dividend/share 1.2 EUR, yield 6.3%.

YearDividends/share
FY20250.5 EUR
FY20240.5 EUR

About M1 Kliniken AG

M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, Croatia, Hungary, Bulgaria, and Romania. It operates through Beauty and Trade segments. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is M1 Kliniken AG's market cap?

M1 Kliniken AG's market capitalization is EUR 345.90M.

What is M1 Kliniken AG's P/E ratio?

M1 Kliniken AG's price-to-earnings (P/E) ratio is 15.5.

Does M1 Kliniken AG pay a dividend?

M1 Kliniken AG has a dividend yield of 6.3%.

What does M1 Kliniken AG do?

M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, Croatia, Hungary, Bulgaria, and Romania. It operates through Beauty and Trade segments. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin.